Cardiovascular Disease in Acromegaly
References
- Melmed S. Acromegaly pathogenesis and treatment. J Clin Invest. 2009 Nov 2; 119 11: 3189– 202.
- Saccà L , Napoli R , Cittadini A. Growth hormone, acromegaly, and heart failure: an intricate triangulation. Clin Endocrinol (Oxf). 2003 Dec; 59 6: 660– 71.
- Troncoso R , Ibarra C , Vicencio JM , Jaimovich E , Lavandero S. New insights into IGF-1 signaling in the heart. Trends Endocrinol Metab. 2014 Mar; 25 3: 128– 37.
- Lu C , Schwartzbauer G , Sperling MA , Demonstration of direct effects of growth hormone on neonatal cardiomyocytes. J Biol Chem. 2001 Jun 22; 276 25: 22892– 900.
- Timsit J , Riou B , Bertherat J , Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle. J Clin Invest. 1990 Aug; 86 2: 507– 15.
- Ito H , Hiroe M , Hirata Y , Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation. 1993 May; 87 5: 1715– 21.
- Lombardi G , Di Somma C , Grasso LF , Savanelli MC , Colao A , Pivonello R. The cardiovascular system in growth hormone excess and growth hormone deficiency. J Endocrinol Invest. 2012 Dec; 35 11: 1021– 9.
- Isgaard J , Arcopinto M , Karason K , Cittadini A. GH and the cardiovascular system: an update on a topic at heart. Endocrine. 2015 Feb; 48 1: 25– 35.
- Matta MP Caron P. Acromegalic cardiomyopathy: a review of the literature. Pituitary. 2003; 6 4: 203– 7.
- Bogazzi F , Lombardi M , Strata E , High prevalence of cardiac hypertrophy without detectable signs of fibrosis in patients with untreated active acromegaly: an in vivo study using magnetic resonance imaging. Clin Endocrinol (Oxf). 2008 Mar; 68 3: 361– 8.
- dos Santos Silva CM , Gottlieb I , Volschan I , Low frequency of cardiomyopathy using cardiac magnetic resonance imaging in an acromegaly contemporary cohort. J Clin Endocrinol Metab. 2015 Dec; 100 12: 4447– 55.
- Arcopinto M , Bobbio E , Bossone E , The GH/IGF-1 axis in chronic heart failure. Endocr Metab Immune Disord Drug Targets. 2013 Mar; 13 1: 76– 91.
- Mosca S , Paolillo S , Colao A , Cardiovascular involvement in patients affected by acromegaly: an appraisal. Int J Cardiol. 2013 Sep 1; 167 5: 1712– 8.
- Colao A. Improvement of cardiac parameters in patients with acromegaly treated with medical therapies. Pituitary. 2012 Mar; 15 1: 50– 8.
- Maison P , Tropeano AI , Macquin-Mavier I , Giustina A , Chanson P. Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis. J Clin Endocrinol Metab. 2007 May; 92 5: 1743– 7.
- De Marinis L , Bianchi A , Mazzotti G , The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. Pituitary. 2008; 11 1: 13– 20.
- Kuhn E , Maione L , Bouchachi A , Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study. Eur J Endocrinol. 2015 Nov; 173 5: 693– 702.
- Attal P Chanson P. Endocrine aspects of obstructive sleep apnea. J Clin Endocrinol Metab. 2010 Feb; 95 2: 483– 95.
- Deray G , Rieu M , Devynck MA , Evidence of an endogenous digitalis-like factor in the plasma of patients with acromegaly. N Engl J Med. 1987 Mar 5; 316 10: 575– 80.
- Colao A , Ferone D , Marzullo P , Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev. 2004 Feb; 25 1: 102– 52.
- Yaron M , Izkhakov E , Sack J , Arterial properties in acromegaly: relation to disease activity and associated cardiovascular risk factors. Pituitary. 2016 Jun; 19 3: 322– 31.
- Akutsu H , Kreutzer J , Wasmeier G , Acromegaly per se does not increase the risk for coronary artery disease. Eur J Endocrinol. 2010 May; 162 5: 879– 86.
- Berg C , Petersenn S , Lahner H , ; Investigative Group of the Heinz Nixdorf Recall Study and the German Pegvisomant Observational Study Board and Investigators. Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control. J Clin Endocrinol Metab. 2010 Aug; 95 8: 3648– 56.
- Bogazzi F , Battolla L , Spinelli C , Risk factors for development of coronary heart disease in patients with acromegaly: a five-year prospective study. J Clin Endocrinol Metab. 2007 Nov; 92 11: 4271– 7.
- Courville C Mason VR. The heart in acromegaly. Arch Intern Med. 1938; 61: 704– 73.
- Cannavo S , Almoto B , Cavalli G , Acromegaly and coronary disease: an integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography. J Clin Endocrinol Metab. 2006 Oct; 91 10: 3766– 72.
- Chemla D , Attal P , Maione L , Impact of successful treatment of acromegaly on overnight heart rate variability and sleep apnea. J Clin Endocrinol Metab. 2014 Aug; 99 8: 2925– 31.
- Davi' MV , Dalle Carbonare L , Giustina A , Sleep apnea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Eur J Endocrinol. 2008 Nov; 159 5: 533– 40.
- Orosz A , Csajbók É , Czékus C , Increased Short-Term Beat-To-Beat Variability of QT Interval in Patients with Acromegaly. PLoS One. 2015 Apr 27; 10 4: e0125639.
- Maffei P , Martini C , Milanesi A , Late potentials and ventricular arrhythmias in acromegaly. Int J Cardiol. 2005 Sep 30; 104 2: 197– 203.
- Lombardi G , Colao A , Marzullo P , Biondi B , Palmieri E , Fazio S ; Multicenter Italian Study Group on Lanreotide. Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study. J Endocrinol Invest. 2002 Dec; 25 11: 971– 6.
- Colao A , Spinelli L , Marzullo P , High prevalence of cardiac valve disease in acromegaly: an observational, analytical, case-control study. J Clin Endocrinol Metab. 2003 Jul; 88 7: 3196– 201.
DOI: https://doi.org/10.14797/mdcj-13-2-64 | Journal eISSN: 1947-6108
Language: English
Page range: 64 - 67
Published on: Apr 1, 2017
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2017 Morali D. Sharma, Anh V. Nguyen, Spandana Brown, Richard J. Robbins, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.